Biblio

5 resultats trouvés
Filtres: Auteur is Ferreri, F.  [Clear All Filters]
A
Bourla A., Chaneac E., Poulet E., Haffen E., Ogorzelec L., Guinchard C., Ferreri F., Mouchabac S..  2020.  Acceptability, attitudes and knowledge towards Transcranial Magnetic Stimulation (TMS) among psychiatrists in France. ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE. 46:88-95.
Bourla A., Ferreri F., Ogorzelec L., Guinchard C., Mouchabac S..  2018.  Assessment of mood disorders by passive data gathering: The concept of digital phenotype versus psychiatrist's professional culture. ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE. 44:168-175.
G
Costemale-Lacoste J.F, K. Asmar E, Colle R., Feve B., Verstuyft C., Trabado S., Ferreri F., Haffen E., Polosan M., Becquemont L. et al..  2017.  GSK-3beta rs334558 is associated with severe insomnia in patients with major depressive episode, but not with remission after antidepressant treatment. EUROPEAN NEUROPSYCHOPHARMACOLOGY. 27:S793-S794.
Costemale-Lacoste J.F, K. Asmar E, Colle R., Feve B., Verstuyft C., Trabado S., Ferreri F., Haffen E., Polosan M., Becquemont L. et al..  2017.  GSK-3beta rs334558 is associated with severe insomnia in patients with major depressive episode, but not with remission after antidepressant treatment. EUROPEAN NEUROPSYCHOPHARMACOLOGY. 27:S793-S794.
Costemale-Lacoste J.F, K. Asmar E, Colle R., Feve B., Verstuyft C., Trabado S., Ferreri F., Haffen E., Polosan M., Becquemont L. et al..  2017.  GSK-3beta rs334558 is associated with severe insomnia in patients with major depressive episode, but not with remission after antidepressant treatment. EUROPEAN NEUROPSYCHOPHARMACOLOGY. 27:S793-S794.